Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Tuman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|May 28, 1993
A novel series of N-(1-aminoalkylidene)carboximidamides as potential hypoglycemic agentsH J Breslin, M J Kukla, R W Tuman, et al.
Journal of Medicinal Chemistry|September 1, 1989
Carbohydrate biguanides as potential hypoglycemic agentsA B Reitz, R W Tuman, C S Marchione, et al.
Journal of Steroid Biochemistry|January 1, 1989
Aromatase inhibition by R 76713: experimental and clinical pharmacologyW Wouters, R De Coster, R W Tuman, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 20, 1990
New non-steroidal aromatase inhibitors: focus on R76713R De Coster, W Wouters, C R Bowden, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferasesZ Yan, G W Caldwell, D Gauthier, et al.
British Journal of Cancer|November 15, 2007
R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignanciesJ Arts, P Angibaud, A Mariën, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|May 28, 1993
A novel series of N-(1-aminoalkylidene)carboximidamides as potential hypoglycemic agentsH J Breslin, M J Kukla, R W Tuman, et al.
Journal of Medicinal Chemistry|September 1, 1989
Carbohydrate biguanides as potential hypoglycemic agentsA B Reitz, R W Tuman, C S Marchione, et al.
Journal of Steroid Biochemistry|January 1, 1989
Aromatase inhibition by R 76713: experimental and clinical pharmacologyW Wouters, R De Coster, R W Tuman, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 20, 1990
New non-steroidal aromatase inhibitors: focus on R76713R De Coster, W Wouters, C R Bowden, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferasesZ Yan, G W Caldwell, D Gauthier, et al.
British Journal of Cancer|November 15, 2007
R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignanciesJ Arts, P Angibaud, A Mariën, et al.
Pageof 2